Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline adjunctive treatment for unipolar depression
ACTRN12612000283875Phase 3Completed
- Sponsor
- Mental Health Research Institute
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised trial in major depressive disorder (MDD) comparing Minocycline adjunctive arm with Placebo adjunctive arm (2 arms). Primary endpoint: Change in depressive symptoms. Started Aug 2013; status: completed.
02
Drugs
minocycline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ACTRN12612000283875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000283875.